Peter Powchik
CIK 1377247 · SVP Clinical Development & Reg · last filed 2023-10-11
Peter Powchik is a SVP Clinical Development & Reg who has filed 30 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for VAXX, was dated Oct 11, 2023. Across all open-market trades the lifetime net is −$41.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.77M
2
30
-$40.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Vaxxinity, Inc. (VAXX) Delisted | Director | 225,858 | $0.11 | $25.1K | $0 | 4 | 2023-10-11 |
| REGN | SVP Clinical Development & Reg | 27,388 | $612.14 | $16.77M | -$40.97M | 26 | 2016-12-19 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-11 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-23 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-19 | REGN | Mixed | — | $0 | EDGAR |
| 2015-12-18 | REGN | Mixed | +1,921 | $99.9K | EDGAR |
| 2015-08-17 | REGN | Mixed | — | -$27.75M | EDGAR |
| 2015-01-05 | REGN | Mixed | — | -$9.03M | EDGAR |
| 2014-12-22 | REGN | Exer (M) | +3,264 | $100.0K | EDGAR |
| 2014-12-18 | REGN | Grant (A) | — | $0 | EDGAR |